Skip to Content

Anti-osteoporotic treatment does reduce the risk of fracture in real-life data

Randomized clinical trials suggest that anti-osteoporotic treatments increase bone mineral density (BMD) and hence reduce the risk of fractures. In this longitudinal cohort study, MD Giovanni Adami, presents the real-life effectiveness of anti-osteoporotic treatment in women at high risk of fracture.

Read more: Abstract: OP0239 Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study.

Giovanni Adami

Lue artikkeli

Jos olet lääkäri, farmaseutti tai rajatun lääkkeenmääräämisoikeuden omaava sairaanhoitaja, pääset lukemaan artikkelin kirjautumalla käyttäjäksi BestPractice Nordic -sivustolle.

Back to top